TP53 and cancer: We hypothesize that p60AmotL2-expressing invading cancer cells have altered chromatin dynamics and chromatin accessibility relative to normal cells, which in turn makes these cells more susceptible to BETi-induced cell death, potentially by p53-related pro-apoptotic signaling pathways.